Soluble PD-L1 in blood has been studied as a biomarker for liquid biopsies, along with histological PD-L1 expression in tumor tissue, and high soluble PD-L1 reportedly relates to poor prognoses in various cancers, including lymphomas [9,10,11]. The gene discussed is CD274; the disease is neoplasm.